Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation

BMJ. 2013 Jun 11:346:f3782. doi: 10.1136/bmj.f3782.
No abstract available

Publication types

  • News

MeSH terms

  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • England
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Incretins / adverse effects*
  • Male
  • Pancreatic Neoplasms / chemically induced*
  • Pancreatitis / chemically induced*
  • Product Surveillance, Postmarketing*
  • Thyroid Neoplasms / chemically induced*
  • United States
  • United States Food and Drug Administration

Substances

  • Hypoglycemic Agents
  • Incretins